drugset / Trial / NCT05147675

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA

NCT05147675

NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.

Timeline

Start
2022-12-01
Primary completion
2027-12-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloRx Cell therapy 1e+08 cells Intravenous

Indications